SRPT - Sarepta Therapeutics, Inc.
16.09
0.220 1.367%
Share volume: 2,068,645
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$15.87
0.22
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-01-2024 | 08-07-2024 | 11-06-2024 | 02-28-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | |
| Total revenue | 413.464 M | 362.931 M | 467.172 M | 658.412 M | 744.856 M | 611.091 M | 399.356 M | |
| Cost of revenue | 50.559 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 362.905 M | 362.931 M | 467.172 M | 658.412 M | 744.856 M | 611.091 M | 399.356 M | |
| 0.01% | 28.72% | 40.94% | 13.13% | -17.96% | -34.65% | |||
| Operating expenses | 327.399 M | 318.486 M | 352.683 M | 363.826 M | 907.077 M | 342.289 M | 310.783 M | |
| Selling general and admin | 127.003 M | 138.796 M | 128.200 M | 163.873 M | 133.629 M | 137.897 M | 91.893 M | |
| Research and development | 200.396 M | 179.690 M | 224.483 M | 199.953 M | 773.448 M | 204.392 M | 218.890 M | |
| Total expenses | 378.559 M | 363.632 M | 444.976 M | 496.731 M | 1.045 B | 495.514 M | 502.745 M | |
| -3.94% | 22.37% | 11.63% | 110.42% | -52.59% | 1.46% | |||
| Operating income | 34.905 M | -701.000 K | 22.196 M | 161.681 M | -300.386 M | 115.577 M | -103.389 M | |
| Ebit | 34.905 M | 13.577 M | 34.006 M | 171.743 M | -383.518 M | 153.638 M | -55.436 M | |
| Pretax income | 41.448 M | 13.577 M | 34.006 M | 171.743 M | -383.518 M | 153.638 M | -194.049 M | |
| -67.24% | 150.47% | 405.04% | -323.31% | -140.06% | -226.30% | |||
| Income tax | 5.329 M | 7.117 M | 395.000 K | 12.694 M | 63.990 M | -43.254 M | -14.102 M | |
| Net income basic | 36.119 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | ||||||||
| Net income | 36.119 M | 6.460 M | 33.611 M | 159.049 M | -447.508 M | 196.892 M | -179.947 M | |
| -82.11% | 420.29% | 373.21% | -381.36% | 144.00% | -191.39% |